ACAD
27.6
+1.12
+4.23%
AEMD
4.625
+0.045
+0.983%
APRI
1.27
+0.01
+0.79%
ARNA
1.445
+0.045
+3.214%
ATEC
5.05
-0.04
-0.79%
CNAT
1.78
+0.03
+1.71%
CRXM
0.17
-0.01
-5.19%
CYTX
1.508
+0.008
+0.5000%
DXCM
64.26
+0.92
+1.45%
GNMK
11.305
-0.045
-0.396%
HALO
11.44
+0.21
+1.87%
ILMN
127.87
+0.15
+0.12%
INNV
0.251
-0.003
-1.30315%
INO
6.95
+0.13
+1.9047%
ISCO
1
-0.15
-13.04%
ISIS
0
0.00
0.00%
LGND
104.76
+1.27
+1.23%
LPTN
2.5
-0.05
-1.9569%
MBVX
3.82
+0.25
+7.00%
MEIP
1.61
+0.03
+1.90%
MNOV
7.03
-0.01
-0.14%
MRTX
5.05
-0.2
-3.81%
MSTX
0.082
-0.004
-5.202%
NBIX
43.79
+0.57
+1.32%
NUVA
63.36
-0.05
-0.08%
ONCS
1.288
+0.008
+0.5938%
ONVO
2.98
+0.09
+3.11%
OREX
1.895
+0.075
+4.121%
OTIC
15.75
+0.4
+2.61%
QDEL
21.85
-0.46
-2.06%
RCPT
0
0.00
0.00%
RGLS
2.375
-0.025
-1.042%
RMD
59.61
+0.05
+0.08%
SCIE
0.001
+0.00
+4.0000%
SPHS
2.75
+0.12
+4.56%
SRNE
5.175
-0.075
-1.429%
TROV
2.675
+0.125
+4.902%
VICL
2.31
0.00
-0.0043%
ZGNX
13.4
+0.7
+5.51%
ACAD
27.6
+1.12
+4.23%
AEMD
4.625
+0.045
+0.983%
APRI
1.27
+0.01
+0.79%
ARNA
1.445
+0.045
+3.214%
ATEC
5.05
-0.04
-0.79%
CNAT
1.78
+0.03
+1.71%
CRXM
0.17
-0.01
-5.19%
CYTX
1.508
+0.008
+0.5000%
DXCM
64.26
+0.92
+1.45%
GNMK
11.305
-0.045
-0.396%
HALO
11.44
+0.21
+1.87%
ILMN
127.87
+0.15
+0.12%
INNV
0.251
-0.003
-1.30315%
INO
6.95
+0.13
+1.9047%
ISCO
1
-0.15
-13.04%
ISIS
0
0.00
0.00%
LGND
104.76
+1.27
+1.23%
LPTN
2.5
-0.05
-1.9569%
MBVX
3.82
+0.25
+7.00%
MEIP
1.61
+0.03
+1.90%
MNOV
7.03
-0.01
-0.14%
MRTX
5.05
-0.2
-3.81%
MSTX
0.082
-0.004
-5.202%
NBIX
43.79
+0.57
+1.32%
NUVA
63.36
-0.05
-0.08%
ONCS
1.288
+0.008
+0.5938%
ONVO
2.98
+0.09
+3.11%
OREX
1.895
+0.075
+4.121%
OTIC
15.75
+0.4
+2.61%
QDEL
21.85
-0.46
-2.06%
RCPT
0
0.00
0.00%
RGLS
2.375
-0.025
-1.042%
RMD
59.61
+0.05
+0.08%
SCIE
0.001
+0.00
+4.0000%
SPHS
2.75
+0.12
+4.56%
SRNE
5.175
-0.075
-1.429%
TROV
2.675
+0.125
+4.902%
VICL
2.31
0.00
-0.0043%
ZGNX
13.4
+0.7
+5.51%
Home » Archive by Category

Xconomy

Tyler Jacks, Cancer Moonshot Panel Co-Chair, Discusses Roadmap

September 9, 2016 – 3:00 am

The Obama administration wants to speed up cancer research with its “Cancer Moonshot” program—packing 10 years’ worth of work on prevention and treatment programs into five is…

[[Click headline to continue reading.]]

Retrophin Drug Licensed by Shkreli Shows Positive Phase 2 Results

September 7, 2016 – 2:52 pm

Retrophin, the drug developer founded by controversial former biotech executive Martin Shkreli, has posted positive results from a midstage study for its treatment for a rare kidney disease. San…

[[Click headline to continue reading.]]

Immunotherapy Clinical Tests Spur Hope, and Plenty of Headaches

September 7, 2016 – 3:30 am

Thanks to remarkable results in a small group of patients, including former U.S. President Jimmy Carter, cancer immunotherapy has spurred talk of once impossible-to-imagine cures and has gained its…

[[Click headline to continue reading.]]

Bio Roundup: RIP Roger Tsien, Novartis CAR-T Wheel, Zika News & More

September 2, 2016 – 3:19 am

A man who helped shed light—fluorescent light—on biology died far too early, at the age of 64. Nobel Prize winner Roger Tsien, a UC San Diego chemist, passed away in Oregon this week. No…

[[Click headline to continue reading.]]

UC San Diego Nobel Laureate Roger Tsien Dies at 64

August 31, 2016 – 9:38 pm

Roger Tsien, a UC San Diego scientist who shared the 2008 Nobel Prize in chemistry for research that led to the development of fluorescent proteins used to illuminate tissue and track biological…

[[Click headline to continue reading.]]

Synthetic Genomics Creates Host Organism Optimized for Bio Industry

August 29, 2016 – 8:00 am

Scientists from Synthetic Genomics, the San Diego-based industrial biotech, have re-engineered a fast-growing microorganism found in salt marsh mud to maximize its production of proteins and to…

[[Click headline to continue reading.]]

The XX Factor: Fixing Biotech’s Gender Imbalance in the C-Suite

August 29, 2016 – 12:00 am

Women continue to be vastly under-represented in management and executive-level positions throughout the life science industry—an inequity that came into the spotlight earlier this year when a…

[[Click headline to continue reading.]]

Bio Roundup: Mylan’s Shock, Hillary’s 3%, Duchenne Lessons & More

August 26, 2016 – 4:55 am

It was the tweet heard around the biotech world, again. Mylan bumped up the price of the EpiPen 400 percent, presidential nominee Hillary Clinton responded with a tirade against drug price hikes,…

[[Click headline to continue reading.]]

Duchenne Lessons: Advocates For Rare Spinal Disease Have Eyes on FDA

August 26, 2016 – 3:40 am

[Updated, 1:09 pm ET, see below] Heather and Jessica Tomko will tell you that they’re nothing alike. They’ve got different interests, different tastes in movies, television, and music. If Jessica…

[[Click headline to continue reading.]]

Who’s to Blame for Inflated Health Insurance Costs?

August 24, 2016 – 8:51 am

How often would you go to the doctor if you had to pay for a big chunk out of pocket—or how about if it was completely free? The amount of health care we consume depends on how good our health…

[[Click headline to continue reading.]]